SEHK:460Pharmaceuticals
Sihuan Pharmaceutical Holdings Group (SEHK:460) Looks Pricey On 2026 Earnings Guidance
Sihuan Pharmaceutical Holdings Group (SEHK:460) has issued new earnings guidance for the first half of 2026, indicating a significant increase in net profit supported by medical aesthetics, drug commercialization progress, associate profits and asset restructuring gains.
See our latest analysis for Sihuan Pharmaceutical Holdings Group.
The earnings guidance arrives after a mixed period for Sihuan Pharmaceutical Holdings Group, with the share price at HK$0.93, a 1 month share price return of...